Carragelose

DEVICE2 trials

Sponsors

Marinomed Biotech AG

Conditions

Covid19Dry Eye Syndromes

Unknown Phase

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

CompletedNCT04793984

Marinomed Biotech AGCovid19

Start: 2021-03-08End: 2022-07-30Updated: 2022-08-29

Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye

CompletedNCT06262100

Marinomed Biotech AGDry Eye Syndromes

Start: 2024-01-15End: 2024-07-30Updated: 2024-12-09